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STUDIES OF HYPOXEMIC/ 
REOXYGENATION INJURY: 
WITHOUT AORTIC 
CLAMPING 
VIII. Counteraction of 
oxidant damage by 
exogenous glutamate and 
aspartate 
Previous studies show that (1) hypoxemia depletes immature myocardium of 
amino acid substrates and their replenishment improves isehemic tolerance, 
(2) reoxygenation cardiopulmonary b pass causes oxygen-mediated damage 
without added ischemia, and (3) this damage may be related to the nitric 
oxide-L-arginine pathway that is affected by amino acid metabolism. This 
study tests the hypothesis that priming the cardiopulmonary b pass circuit 
with glutamate and aspartate limits reoxygenation damage. Of 22 immature 
Duroc-Yorkshire piglets (<3 weeks old), five were observed over a 5-hour 
period (control), and five others underwent 30 minutes of CPB without 
hypoxemia (cardiopulmonary b pass control). Twelve others became hypox- 
emic by reducing ventilator inspired oxygen fraction to 6% to 7% (oxygen 
tension about 25 mm Hg) before reoxygenation cardiopulmonary b pass for 
30 minutes. Of these five were untreated (no treatment), and the cardiopul- 
monary bypass circuit was primed with 5 mmol/L glutamate and aspartate in 
seven others (treatment). Left ventricular function before and after bypass was 
measured by inscribing pressure-volume loops (end-systolic elastance). Myo- 
cardial conjugated diene levels were measured to detect lipid peroxidation, and 
antioxidant reserve capacity was tested by incubating cardiac muscle with the 
oxidant t-butylhydroperoxide to determine the susceptibility to subsequent 
oxidant injury. CPB (no hypoxemia) allowed complete functional recovery 
without changing conjugated dienes and antioxidant reserve capacity, whereas 
reoxygenation i jury developed in untreated hearts. This was characterized by 
reduced contractility (elastanee nd-systolic recovered only 37% -+ 8%*), 
increased conjugated iene levels (1.3 - 0.1 vs 0.7 - 0.1"), and decreased 
antioxidant reserve capacity (910 -+ 59 vs 471 - 30 malondialdehyde nmol/g 
protein at 2 mmol/L t-butylhydroperoxide*). In contrast, priming the cardio- 
pulmonary bypass circuit with glutamate and aspartate resulted in signifi- 
cantly better left ventricular functional recovery (75% - 8% vs 37% -+ 8%*), 
minimal conjugated iene production (0.8 -+ 0.1 vs 1.3 - 0.1"), and improved 
antioxidant reserve capacity (726 -+ 27 vs 910 -+ 59 malondialdehyde nmol/g 
protein*) (*p < 0.05 vs cardiopulmonary b pass control). We conclude that 
reoxygenation of immature hypoxemic piglets by the initiation of cardiopul- 
monary bypass causes myocardial dysfunction, lipid peroxidation, and reduced 
tolerance to oxidant stress, which may increase vulnerability to subsequent 
ischemia (i.e., aortic crossclamping). These data suggest hat supplementing 
the prime of eardiopulmonary b pass circuit with glutamate and aspartate 
may reduce these deleterious consequences of reoxygenation. (J THORAC 
CARDIOVASC SURG 1995;110:1228-34) 
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R ecent experimental t' 2 reports suggest hat unin- tended reoxygenation i jury of hypoxemic myo- 
cardium occurs dur ing initiation of extracorporeal 
circulation. The damage is characterized by lipid 
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peroxidation and myocardial dysfunction and may 
contribute to postbypass dysfunction after surgical 
correction of cyanotic heart defects, because subse- 
quent ischemia is needed for cardiac repair. 
Our previous studies show that hypoxemia-re- 
lated disorders of amino acid metabolism may en- 
hance reoxygenation-induced myocardial dysfunc- 
tion because (1) hypoxemia depletes the immature 
myocardium of amino acid substrates needed for 
energy production, 3 (2) replenishment of glutamate 
and aspartate during hypoxemia improves ischemic 
tolerance, 4 and (3) prereoxygenation treatment with 
an intravenous metabolic support solution that in- 
cludes these amino acids limits oxidant damage and 
reoxygenation-induced myocardial dysfunction in 
hypoxemic immature piglets, s 
Recent studies implicate the L-arginine-nitric ox- 
ide (-NO) pathway in the pathogenesis of reoxygen- 
ation damage. 5 Amino acids also affect the L-argi- 
nine cationic transport system and may therefore 
reduce lipid peroxidation by inhibiting L-arginine 
uptake and subsequent NO synthesis. 6'7 This study 
tests the hypothesis that priming the cardiopulmo- 
nary bypass (CPB) circuit with glutamate and aspar- 
tate will reduce lipid peroxidation and improve 
post-CPB functional recovery after reoxygenation 
of the cyanotic immature heart when CPB is 
initiated. 
Material and methods 
Preparation. Twenty-two immature, 2- to 3-week-old 
Yorkshire-Duroc piglets (3 to 5 kg) were premedicated 
with 0.5 mg/kg diazepam intramuscularly, anesthetized 
with 30 mg/kg pentobarbital intraperitoneally followed by 
5 mg/kg intravenously each hour, and the lungs ventilated 
on, a volume-limited respirator (Servo 900D, Siemens- 
Elema, Solna, Sweden) via a tracheostomy. All animals 
received humane care in compliance with the "Principles 
of Laboratory Animal Care" formulated by the National 
Society for Medical Research and the "Guide for the Care 
and Use of Laboratory Animals" published by the Na- 
tional Academy of Sciences, published by the National 
Institutes of Health (NIH Publication No. 86-23, revised 
1985). The surgical preparation, including vessel Cannula- 
tion for CPB and catheter replacement for blood sampling 
and monitoring, is similar to that described previously. 2 
Measurements 
Hemodynamics. Hemodynamic measurements were 
made during control conditions, each 15 minutes during 
hypoxemia, nd 15 minutes and 30 minutes after CPB was 
discontinued. Cardiac output was determined by duplicate 
injections of 1 ml of 4 ° C saline solution into a central 
venous catheter. Cardiac index (CI) and left ventricular 
stroke work index (LVSWI) were calculated with the 
following equations: 
CI (ml/min/kg) -- CO/body weight (kg) 
LVSWI (g. m/kg) = (MAP - LAP) 
× CO × 0.0136/(HR × body weight [kg] 
where MAP is mean aortic pressure, LA is mean left atrial 
pressure, CO is cardiaC output in milliliters per minute, 
and HR is heart rate. 
Left ventricular performance. Left ventricular (LV) 
pressure-volume and ultrasonic crystal signals from 
sonomicrometer crystals placed on the anterior and pos- 
terior LV epicardial surfaces were amplified and digitized 
to inscribe LV pressure-volume loops. A series of pres- 
sure-dimension loops under variable loading conditions 
was generated by rapid transient occlusion of the inferior 
vena cava during a 7-second period of apnea, during 
control conditions, and 30 minutes after CPB was discon- 
tinuedfi 
The end-systolic pressure volume relationship 
(ESPVR) was analyzed by an interactive videographics 
data analysis computer program (Spectrum, Bowman 
Gray School of Medicine, Winston-Salem, N.C.) on an 
386/33 MHz IBM computer (IBM, Armonk, N.Y.), and 
LV performance was described as the slope of linear 
regression (end-systolic elastance lEes]), as described 
previously. 9 Postbypass LV contractility was assessed by 
percent recovery of prebypass control value (percent Ees). 
Volume loading by transfusion to LAP 8 mm Hg was used 
to compare recovery of LVSWI before and after CPB. 
Tissue injury due to oxidants. Myocardial conjugated 
dienes were measured as a marker of lipid peroxidation. 
LV endocardial biopsy specimens were frozen immedi- 
ately and stored in liquid nitrogen; tissue levels of hy- 
droxyconjugated dienes were determined as described by 
Lesnefsky and coworkers) ° 
Antioxidant reserve capacity. In vitro lipid peroxidation 
was measured by the method of Godin and colleagues la to 
assess the antioxidant state or vulnerability to subsequent 
oxidant stress as described previously. 
Experimental Groups 
Control. Five normoxemic piglets were anesthetized, 
instrumented, and observed over a 5-hour period to define 
the stability of an open-chest preparation and provide 
baseline control functional and biochemical data. 
CPB without hypoxemia or reoxygenation. Five piglets 
underwent 30 minutes of CPB without hypoxemia, fol- 
lowed by 30 minutes of observation after CPB to deter- 
mine the effects of CPB per se. 
Hypoxemia and reoxygenation. Twelve piglets were 
made hypoxemic by lowering inspired oxygen fraction 
(Fio2) (6% to 7%) to reduce arterial oxygen tension 
(Pao2) to about 25 mm Hg for up to 120 minutes, followed 
by reoxygenation CPB (Pao2 > 400 mm Hg). CPB was 
started before 120 minutes if mean arterial pressure fell 
below 30 mm Hg and was unresponsive to volume infusion 
or arterial pH could not be maintained above 7.3 by 
NaHCO 3 bolus intravenous infusions. 
No TREATMENT. Five piglets were reoxygenated onCPB 
without amino acid supplementation f the prime of 
extracorporeal circuit, 
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Table. Changes in heart rate, cardiac index, and left ventricular stroke work index during hypoxia/reoxygenation 
Control 15 30 60 End 
Hypoxia (min) Reoxygenation 
30 min after % of 
CPB control 
Heart rate (beats/min) 
CPB i69 ± 11 
Control 154 ± 9 
NoRx 170 ± 8 183 + 9 
G/A 189 ± 17 190 ± 5 
Cardiac index (ml/min/kg) 
CPB 83 ± 12" 
Control 87 ± 8* 
NoRx 120 ± 12 135 + 13 
G/A 134 _+ 12?$ 133 + 14 
LVSWI (g. m/kg) 
CPB 0.43 ± 0.09 
Control 0.61 ± 0.09 
NoRx 0.71 _+ 0.12 0.70 ± 0.11 
G/A 0.57 ± 0.07 0.50 ± 0.08 
176 ± 10 
166 ± 9 
193 ± 9 198 ± 10 177 ± 7 163 ± 8 
210 ± 7 185 ± 10 169 ± 8 160 ± 6 
148 ± 19 128 ± 21 103 ± 12 
158 ± 30 73 ± 30* 91 ± 21 
0.79 ± 0.13 0.66 ± 0.14 0.35 ± 0.07 
0.74 ± 0.15 0.43 ± 0.08 0.27 ± 0.08 
75 ± 8 (111 ± 24*) 
80 ± 7 (98 ± 10') 
70 ± 7 (62 2 6) 
103 + 11"? (77 ± 14) 
0.52 -+ 0.06* (126 -+ 33*) 
0.64 ± 0.09 (101 ± 14) 
0.29 _+ 0.04 (52 ± 11) 
0.40 ± 0.07 (72 -+ 8*) 
No Rx, No treatment; G/A, piglets with glutamate/aspartate supplementation; LVSWI, left ventricular stroke work index; CPB, 
*p < 0.05 vs no treatment. 
tP < 0.05 vs CPB. 
:~p < 0.05 vs control. 
cardiopulmonary b pass. 
GLUTAMATE AND ASPARTATE IN CPB PRIME. In seven 
piglets the prime of the CPB circuit was supplemented 
with 5 mmol/L glutamate and aspartate. A 30-minute 
period of reoxygenation on CPB was followed by 30 
minutes of observation after CPB before final functional 
assessments w~re performed and specimens for biochem- 
ical analyses were obtained. At the end of each experi- 
ment, the brain and thoracic and intraabdominal organs 
were inspected visually to confirm closure of the foramen 
ovale and arterial ductus. 
Statistics. Data were analyzed with the use of the 
StatView V2.0 program (Abacus Concepts Inc., Berkeley, 
Calif.) on a Macintosh IIci computer (Apple, Inc., Cuper- 
tino, Calif.). Analysis of variance was used for intergroup 
comparison and the paired Student  test used for com- 
parison of variables within experimental groups. Differ- 
ences were considered significant at the probability level 
ofp < 0.05. Group data were expressed as mean plus or 
minus standard error of the mean. 
Results 
CI and stroke work rose initially after hypoxemia 
but declined during the second hour; premature 
institution of CPB because of hemodynamic d~teri- 
oration was needed in seven of 12 piglets (Table). 
The average tolerated hypoxemic period was 102 _+ 
15 minutes, with nO difference in mean duration of 
hypoxemia in pig!ets reoxygenated on CPB with and 
without amino acid supplementation f the extra- 
corporeal circuit priming fluid. 
Ventricular performance. Post-CPB function was 
unaltered in piglets undergoing CPB without pre- 
ceding hypoxemia (CPB), becafise Ees recovered to 
98% of control values and LVSW[ (at 8 mm Hg LAP) 
recovered to the same level recorded before CPB was 
started. In contrast, Ees recovered only 38% _+ 12% of 
prehypoxemic control values (p< 0.05 vs CPB) after 
reoxygenation of CPB without altering the pump 
prime (no treatment). Supplementation f the prime 
with glutamate and aspartate resulted in 75% _+ 8% 
recovery of LV contractility (p < 0.05 vs no treatment) 
(Fig. 1). LVSWI recovered only 52% in untreated 
piglets, whereas glutamate and aspartate supplemen- 
tation of the CPB prime resulted in 72% recovery (p < 
0.05 vs ~ no treatment, after transfusion to LAP of 8 mm 
Hg (Table). 
Conjugated dienes. LV conjugated ienes (Fig. 
2) were comparable with those in normoxemic in- 
strumented piglets after CPB without hypoxemia. 
Reoxygenation on CPB (no treatment) increased 
myocardial tissue conjugation diene levels 89% 
above control values (0.7 _+ 0.1 vs 1.3 + 0.2; p < 
0.05). Conjugated iene levels after CPB remained 
in the normal range after the addition of glutamate 
and aspartate to the CPB prime, with final values 
significantly lower than in untreated piglets (0.83 +_ 
0.1 vs 1.3 _+ 0.1; p < 0.05). 
Antioxidant reserve capacity. Antioxidant re- 
serve capacity was unaltered by CPB (Fig. 3). Con- 
versely, reoxygenation o  CPB reduced antioxidant 
reserve capacity, as malondialdehyde increased sig- 
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Fig. 1. LV contractility. LV Ees after discontinuation of CPB, expressed as percent of individual 
prehypoxemic values. CPB: piglets undergoing CPB without hypdxemia; no treatment: piglets undergoing 
reoxygenation without treatment; Glu/Asp: piglets undergoing reoxygenation  CPB with glutamate/ 
aspartate supplementation. *p < 0.05 vs no treatment; ?p < 0.05 CPB. 
nificantly in myocardial homogenates incubated in 
the oxidant -butylhydroperoxide. These adverse f- 
fects of reoxygenation were limited by adding gluta- 
mate and aspartate to the extracorporeal circuit 
(Fig. 3). 
Discussion 
These data indicate that supplementation f the 
CPB circuit prime with glutamate and aspartate 
reduces the lipid peroxidation and myocardial dys- 
function that would otherwise occur when hypox- 
emic immature hearts are reoxygenated when CPB 
is started. These findings are consistent with our 
previous observations.5 Prior studies of glutamate 
and aspartate in immature find adult hearts focused 
primarily on the capacity of these amino acids to 
maintain anaerobiosis during ischemia 12-16 and re- 
store aerobic metabolism by replenistiing substrates 
depleted by hypoxemia nd ischemia)' 17, 18 This 
report provides the first direct evidence that amino 
acid supplementation limits lipid peroxidation after 
reoxygenation. 
Hypoxemia or ischemia reduces cytosolic oncen- 
trations of glutamate and aspartatel2'13; these 
amino acids are used to produce adenosine triphos- 
phate anaerobically via substrate phosphorylation 
and thereby become less available for resumption of 
aerobic metabolism via the Krebs cycle after reoxy- 
genation. Studies by Pisarenko find coworkers 12 
indicate that the pool size of key amino acids 
influences postischemic recovery of both cellular 
energy supply and contractile function. Further- 
more, it seems that only those amino acids that can 
be transformed to glutamate and aspartate are 
effective in maintaining cardiac adenine nucleotides 
and limiting ischemic injury. 14' 15 
One recognized aspect of the improved recovery 
afforded by 'amino acid supplementation of the 
extracorp0real circuit may be via the mechanisms of
ensuring their availability for aerobic adenosine 
triphosphate productionafter reoxygenation. 18 The 
capacity of amino acids to limit oxidant damage was 
an unanticipated occurrence that may be related to 
the less recognized roles of glutamate and aspartate 
in L-arginine synthesis and L-arginine- .NO pathway. 
In the past, generation of cytotoxic 02 radicals has 
been ascribed predominantly to the Haber-Weiss 
pathway, in which hydroxyl radical (-OH) is the most 
deleterious species. 19 More recently, Beckman and 
colleagues 2° suggested that generation of .OH via 
the Haber-Weiss pathway may be limited in vivo and 
proposed that -NO reacts with superoxide anion 
(02-) to produce peroxynitrite ion (OONO-) that 
degrades homolytically to .OH..NO is a physiologic 
1232 Morita et al. 
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Fig. 2. Conjugated diene content. Biopsy specimen of LV subendocardial muscle taken 30 minutes after 
discontinuation f CPB. Dotted bar shows range of values -+ SE (A233/mg total lipid) from normoxemic 
instrumented control piglets. CPB: piglets undergoing CPB without hypoxemia, no treatment." piglets 
undergoing reoxygenation without reatment; Glu/Asp: piglets undergoing reoxygenation on CPB with 
glutamate/aspartate supplementation. *p < 0.05 vs no treatment; tp < 0.05 CPB. 
modulator of vascular tone and white cell and 
platelet adhesiveness and is known als0 as endothe- 
lial-derived relaxation factor. Reoxygenation is also 
associated with a burst of .NO, 1 and .NO has been 
implicated recently in tissue injury. 1' 2i, 22 
• NO is produced by the interaction of oxygen and 
i~-arginine, and studies imply that L-arginine uptake 
by endothelial cells is essential for sustained NO 
synthesis. 23L-arginine uptake is regulated by a satu- 
ratable cationic amino acid transport system sensi- 
tive to inhibition by i~-orthinine and neutral amino 
acids. 24 Hecker and coworkers 7 showed that glu- 
tamine inhibits endothelial-derived r laxation factor 
release in bovine endothelial cells. Glutamine syn- 
thetase is present in cardiac muscle and converts 
glutamic acid to L-glutamine, 25and L-glutamine is 
synthesized also from aspartate via aspartate amino 
transferase, 26 These observations imply that gluta- 
mate and aspartate, through their conversion to 
L-glutamine, may inhibit L-arginine transport and 
subsequent .NO production in addition to their 
favorable ffect on cardiac energy metabolism. Un- 
fortunately, we did not measure .NO production to 
confirm this suggested mechanism for an antioxi- 
dant action of glutamate and aspartate. 
Glutamate- and aspartate-treated piglets showed 
less severe depletion of antioxidant reserve capacity 
than did untreated piglets, which suggests better 
retention of endogenous antioxidants (e.g., superox- 
ide dismutase, glutathione). This may have limited 
lipid peroxidation after reoxygenation. An alternate 
explanation is that glutamate/aspartate enhanced 
the energy state, thereby increasing the rate of 
restoration of endogenous antioxidants; reduced 
nicotinamide adenine dinucleotide phosphate sup- 
ply from reduced nicotinamide adenine dinucleotide 
via transhydrogenation n mitochondria is essential 
for maintaining the glutathione pool. 27 
The glutamate and aspartate dose (5/xmol/L) was 
derived from our previous studies of intravenous 
metabolic support. 4's The total dose was modified 
to account for the priming volume of the extracor- 
poreal circuit. This dose is (1) consonant with the 
studies, 14 showing a dose-dependent relationship be- 
tween L-glutamate infusion and oxidative phosphory- 
lation, and (2) does not cause neurotoxicity under 
nonhypoxemic or ischemic conditions. 2s Glutamate 
and aspartate are neuroexcitory compounds, ~ so that 
further short- and long-term studies are needed in the 
hypoxem~c setting (with and without circulatory arrest) 
before they can be considered for intravenous clinical 
application. Amino adds, however, have been used to 
surgical advantage in cardioplegic solutions both ex- 
perimentally 29 and clinically 3° in immature hearts. 29' 30 
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Fig. 3. Antioxidant reserve capacity. Vulnerability of hypoxemic reoxygenated myocardium tosubsequent 
oxidant stress is determined by exposing tissue to 0 to 4 mmol/L t-butylhydroperoxide for 30 minutes at 
37 ° C with subsequent measurement of hiobuteric acid-reactive substances. MDA, Malondialdehyde; CPB: 
piglets undergoing CPB without preceding hypoxemia; no treatment." piglets undergoing reoxygenation 
without reatment, Glu/Asp: piglets undergoing reoxygenation CPB with glutamate/aspartate supple- 
mentation. *p < 0.05 vs. no treatment; p < 0.05 CPB, control, t-BHP, t-butylhydroperoxide. 
The recent extended use of cerebral retroperfusion 
may limit use of circulatory arrest and increase the 
potential safety of systemic use of amino acid infusions 
during repair of congenital defects. 
Our findings suggest hat supplementation f the 
CPB prime of the extracorporeal circuit with gluta- 
mate and aspartate may reduce oxidant damage and 
minimize reoxygenation injury, provided subsequent 
studies document that systemic amino acid admin- 
istration is not neurotoxic. Alternatively, a myocar- 
dial-directed approach (adding glutamate and as- 
partate to the cardioplegic solution) may be 
clinically more relevant, because substrate nrich- 
ment may add reduction of oxidant damage to the 
recognized benefits of enhancing metabolic recov- 
ery. 
REFERENCES 
1. Matheis G, Sherman MP, Buckberg GD, Haybron 
DM, Young HH, Ignarro LJ. Role of L-arginine-nitric 
oxide pathway in myocardial reoxygenation i jury. 
Am J Physiol 1992;262:H616-H20. 
2. Ihnken K, Morita K, Buckberg GD, Matheis G, 
Sherman MP, Allen BS, Young HH. Studies of hy- 
poxemic/reoxygenation injury without aortic clamp- 
ing. II. Evidence for reoxygenation damage. J THORAC 
CARDIOVASC SURG 1995;110:891-901. 
3. Julia PL, Kofsky ER, Buckberg GD, Young HH, 
Bugyi HI. Studies of myocardial protection in the 
immature heart: III. Models of ischemic and hypoxic/ 
ischemic injury in the neonatal puppy heart. J THOaAC 
CARDIOVASC SURG 1991;101:14-22. 
4. Julia PL, Young HH, Buckberg GD, Kofsky ER, Bugyi 
HI. Studies of myocardial protection i  the immature 
heart: IV. Improved tolerance of immature myocardium 
to hypoxia nd ischemia by intravenous metabolic sup- 
port. J THORAC CARDIOVASC SURG 1991;101:23-32. 
5. Matheis G, Tixier DB, Buckberg GD, et al. Cardio- 
pulmonary dysfunction produced by reoxygenation f 
immature hypoxemic animals on cardiopulmonary 
bypass: prevention by intravenous metabolic pretreat- 
merit. J THORAC CARDIOVASC SURG 1993;105:513-9. 
6. Sweiry JH, Munoz M, Mann GE. Cis-inhibition and 
trans-stimulation of cationic amino acid transport in 
the perfused rat pancreas. Am J Physiol 1991;261: 
C506-C14. 
7. Hecker M, Mitchell JA, Swierkosz TA, Sessa WC, 
Vane JR. Inhibition by L-glutamine of the release of 
endothelium-derived r laxing factor from cultured 
endothelial cells. Br J Pharmacol 1990;101:237-9. 
1 2 3 4 Morita et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1995 
8. Little WC, Cheng C, Mumma M, Igarashi Y, Vinten- 
Johansen J, Johnston WE. Comparison of measures 
of left ventricular contractile performance derived 
from pressure-volume loops in conscious dogs. Circu- 
lation 1989;80:1378-87. 
9. Sagawa K, Maughan L, Suga H, Sunagawa K. Cardiac 
contraction and the pressure-volume r lationship. 
New York: Oxford University Press, 1988. 
10. Lesnefsky EJ, Fennessey PM, Van Benthuysen KM, 
McMurtry IF, Travis VL, Horwitz LD. Superoxide 
dismutase decreases early reperfusion release of con- 
jugated dienes following regional canine ischemia. 
Basic Res Cardiol 1989;84:191-6. 
11. Godin DV, Ko KM, Garnett ME. Altered antioxidant 
status in the ischemic/reperfused rabbit myocardium: 
effects of allopurinol. Can J Cardiol 1989;5:365-71. 
12. Pisarenko OI, Oleynikov OD, Shulzhenko VS, Stud- 
neva IM, Ryff IM, Kapelko VI. Association of myo- 
cardial glutamate and aspartate pool and functional 
recovery of postischemic heart. Biochem Med Metab 
Biol 1989;42:105-17. 
13. Taegtmeyer H. Metabolic responses to cardiac hy- 
poxia: increased production of succinate by rabbit 
papillary muscle. Circ Res 1978;43:808-15. 
14. Matsuoka S, Marmakani JM, Young HH, Uemura S, 
Nakanishi T. The effect of glutamate on hypoxic new- 
born rabbit heart. J Mol Cell Cardiol 1986;18:897-906. 
15. Rau ER, Shine KI, Gervais A, Douglas AM; Amos 
EC. Enhanced mechanical recovery of anoxic and 
ischemic myocardium by amino acid perfusion. Am J 
Physiol 1979;236:H873-H9. 
16. Julia PL, Young HH, Buckberg GD, Kofsky ER, 
Bugyi HI. Studies of myocardial protection in the 
immature heart. II. Evidence for importance ofamino 
acid metabolism in tolerance to ischemia. J THORAC 
CARDIOVASC SUNG 1990;100:888-95. 
17. Lazar HL, Buckberg GD, Manganaro AM, Becker H. 
Myocardial energy replenishment and reversal of isch- 
emic damage by substrate nhancement of secondary 
blood cardioplegia with amino acids during reperfusion. 
J THONAC CARDXOVASC SUNG 1980;80:350-9. 
18. Rosenkranz ER, Okamoto F, Buckberg GD, Robert- 
son JM, Vinten-Johansen J, Bugyi H. Safety of pro- 
longed aortic clamping with blood cardioplegia. III. 
Aspartate nrichment of glutamate-blood cardiople- 
giG in energy-depleted hearts after ischemic and 
reperfusion i jury. J THORAC CARDIOVASC SUNG 1986; 
91:428-35. 
19. Heffner JE, Repine JE. Pulmonary strategies of 
antioxidant defense. Am Rev Respir Dis 1989;140: 
531-54. 
20. Beckman JS, Beckman TW, Chen J, Marshall PA, 
Freeman BA. Apparent hydroxyl radical production 
by peroxynitrite: implications for endothelial injury 
from nitric oxide and superoxide. Proc Natl Acad Sci 
USA 1990;87:1620-4. 
21. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler 
BG, Simmons RL. Negative inotropic effects of cyto- 
kines on the heart mediated by nitric oxide. Science 
1992;257:387-91. 
22. Brady AJB, Poole-Wilson PA, Harding SE, Warren 
JB. Nitric oxide production within cardiac myocytes 
reduces their contractility in endotoxemia. Am J 
Physiol 1992;263:H1963-HG. 
23. Bogie RG, Coade SB, Moncada S, Pearson JD, Mann 
GE. Bradykinin and ATP stimulate L-arginine uptake 
and nitric oxide release in vascular endothelial cells. 
Biophys Res Comms 1991;180:926-32. 
24. Greene B, Pacitti JA, Souba WW. Characterization f 
L-arginine transport by pulmonary artery endothelial 
cells. Am J Physiol 1993;264:L351-60. 
25. Krivokapich J, Barrio JR, Phelps ME, Watanabe CR, 
Keen RE, Padgett HC, Douglas A, Shine KI. Kinetic 
characterization f 13NH3 and 13N glutamine metabo- 
lism in rabbit heart. Am J Physiol 1984;246:H267-H73. 
26. Bavaverl G, Martin G, Michoudet C. Glutamine 
synthesis from aspartate in guinea-pig renal cortex. 
Biochem J 1990;268:437-42. 
27. Tribble DL, Jones DP. Oxygen dependence of oxida- 
tive stress. Rate of NADPH supply for maintaining 
the GSH pool during hypoxia. Biochem Pharmacol 
1990;39:729-36. 
28. Olney JW, Ho OL. Brain damage in infant mice 
following oral intake of glutamate, aspartate or cys- 
tein. Nature 1970;227:609-10. 
29. Kofsky ER, Julia PL, Buckberg GD, Young HH, Tixier 
D. Studies of myocardial protection in the immature 
heart: V. Safety of prolonged aortic clamping with 
hypocalcemic glutamate/aspartate blood cardioplegia. J 
THORAC CARDIOVASC SUNG 1991;101:33-43. 
30. Drinkwater DCJ, Cushen CK, Laks H, Buckberg GD. 
The use of combined antegrade-retrograde infusion 
of blood cardioplegic solution in pediatric patients 
undergoing heart operation. J THORAC CARDIOVASC 
SUN6 1992;104:1349-55. 
